These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36960215)

  • 1. Anlotinib Enhances the Therapeutic Effect of Bladder Cancer with GSDMB Expression: Analyzed from TCGA Bladder Cancer Database & Mouse Bladder Cancer Cell Line.
    Wang C; Cao Q; Zhang S; Liu H; Duan H; Xia W; Shen H; Wang C
    Pharmgenomics Pers Med; 2023; 16():219-228. PubMed ID: 36960215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. USP24-GSDMB complex promotes bladder cancer proliferation via activation of the STAT3 pathway.
    He H; Yi L; Zhang B; Yan B; Xiao M; Ren J; Zi D; Zhu L; Zhong Z; Zhao X; Jin X; Xiong W
    Int J Biol Sci; 2021; 17(10):2417-2429. PubMed ID: 34326684
    [No Abstract]   [Full Text] [Related]  

  • 3. Correlation of gasdermin B staining patterns with prognosis, progression, and immune response in colorectal cancer.
    Sun L; Wang J; Li Y; Kang Y; Jiang Y; Zhang J; Qian S; Xu F
    BMC Cancer; 2024 May; 24(1):567. PubMed ID: 38711020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative splicing of
    Kong Q; Xia S; Pan X; Ye K; Li Z; Li H; Tang X; Sahni N; Yi SS; Liu X; Wu H; Elowitz MB; Lieberman J; Zhang Z
    Sci Immunol; 2023 Apr; 8(82):eadg3196. PubMed ID: 37115914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma.
    Song F; Hu B; Cheng JW; Sun YF; Zhou KQ; Wang PX; Guo W; Zhou J; Fan J; Chen Z; Yang XR
    Cell Death Dis; 2020 Jul; 11(7):573. PubMed ID: 32709873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-PD-1/Her2 Bispecific Antibody IBI315 Enhances the Treatment Effect of Her2-Positive Gastric Cancer through Gasdermin B-Cleavage Induced Pyroptosis.
    Lin W; Zhang Y; Yang Y; Lin B; Zhu M; Xu J; Chen Y; Wu W; Chen B; Chen X; Liu J; Wang H; Teng F; Yu X; Wang H; Lu J; Zhou Q; Teng L
    Adv Sci (Weinh); 2023 Oct; 10(30):e2303908. PubMed ID: 37587833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anlotinib Overcomes Multiple Drug Resistant Colorectal Cancer Cells via Inactivating PI3K/AKT Pathway.
    Lan W; Zhao J; Chen W; Shang H; Peng J; Lin J
    Anticancer Agents Med Chem; 2021; 21(15):1987-1995. PubMed ID: 33438566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis.
    Cui Y; Zhou Z; Chai Y; Zhang Y
    J Immunol Res; 2021; 2021():7753553. PubMed ID: 34957313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells.
    Zhou Z; He H; Wang K; Shi X; Wang Y; Su Y; Wang Y; Li D; Liu W; Zhang Y; Shen L; Han W; Shen L; Ding J; Shao F
    Science; 2020 May; 368(6494):. PubMed ID: 32299851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GSDMB promotes non-canonical pyroptosis by enhancing caspase-4 activity.
    Chen Q; Shi P; Wang Y; Zou D; Wu X; Wang D; Hu Q; Zou Y; Huang Z; Ren J; Lin Z; Gao X
    J Mol Cell Biol; 2019 Jun; 11(6):496-508. PubMed ID: 30321352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic Antitumor Effects of Anlotinib Combined with Oral 5-Fluorouracil/S-1 via Inhibiting Src/AKT Signaling Pathway in Small-Cell Lung Cancer.
    Xia X; Pi W; Lan Y; Wu X; Lv D; Meng Y; Yang H; Wang W
    Anal Cell Pathol (Amst); 2022; 2022():4484211. PubMed ID: 35757014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combined effect and mechanism of antiangiogenic drugs and PD-L1 inhibitor on cell apoptosis in triple negative breast cancer.
    Li J; Zhang D; Liu Z; Wang Y; Li X; Wang Z; Liang G; Yuan X; Li Y; Komorowski AL; Rozen WM; Orlandi A; Takabe K; Franceschini G; Jerusalem G; Wang X
    Ann Transl Med; 2023 Jan; 11(2):83. PubMed ID: 36819490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gasdermin-B (GSDMB) takes center stage in antibacterial defense, inflammatory diseases, and cancer.
    Sarrio D; Colomo S; Moreno-Bueno G
    FEBS J; 2024 Jul; 291(14):3060-3071. PubMed ID: 37997534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional insights into GSDMB isoforms complex roles in pathogenesis.
    Colomo S; Ros-Pardo D; Oltra SS; Gomez-Puertas P; Sarrio D; Moreno-Bueno G
    Cell Cycle; 2023 Oct; 22(20):2346-2359. PubMed ID: 38037340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of GSDMB in Pyroptosis and Cancer.
    Li L; Li Y; Bai Y
    Cancer Manag Res; 2020; 12():3033-3043. PubMed ID: 32431546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anlotinib Exerts Anti-Cancer Effects on KRAS-Mutated Lung Cancer Cell Through Suppressing the MEK/ERK Pathway.
    Hu H; Liu Y; Tan S; Xie XX; He J; Luo F; Wang L
    Cancer Manag Res; 2020; 12():3579-3587. PubMed ID: 32547195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gasdermin B over-expression modulates HER2-targeted therapy resistance by inducing protective autophagy through Rab7 activation.
    Gámez-Chiachio M; Molina-Crespo Á; Ramos-Nebot C; Martinez-Val J; Martinez L; Gassner K; Llobet FJ; Soriano M; Hernandez A; Cordani M; Bernadó-Morales C; Diaz E; Rojo-Sebastian A; Triviño JC; Sanchez L; Rodríguez-Barrueco R; Arribas J; Llobet-Navás D; Sarrió D; Moreno-Bueno G
    J Exp Clin Cancer Res; 2022 Sep; 41(1):285. PubMed ID: 36163066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gasdermin-B Pro-Tumor Function in Novel Knock-in Mouse Models Depends on the
    Sarrio D; Rojo-Sebastián A; Teijo A; Pérez-López M; Díaz-Martín E; Martínez L; Morales S; García-Sanz P; Palacios J; Moreno-Bueno G
    Front Cell Dev Biol; 2022; 10():813929. PubMed ID: 35281099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anlotinib induces hepatocellular carcinoma apoptosis and inhibits proliferation via Erk and Akt pathway.
    He C; Wu T; Hao Y
    Biochem Biophys Res Commun; 2018 Sep; 503(4):3093-3099. PubMed ID: 30146257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anlotinib Suppressed Ovarian Cancer Progression via Inducing G2/M Phase Arrest and Apoptosis.
    Zhu Y; Wang X; Chen Z; Zhou L; Di X; Fan P; He Z
    J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36614964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.